Design and construction of a novel transpalpebral ophthalmic tonometer by Moinot, Philippe R.
New Jersey Institute of Technology
Digital Commons @ NJIT
Theses Theses and Dissertations
Spring 2008
Design and construction of a novel transpalpebral
ophthalmic tonometer
Philippe R. Moinot
New Jersey Institute of Technology
Follow this and additional works at: https://digitalcommons.njit.edu/theses
Part of the Biomedical Engineering and Bioengineering Commons
This Thesis is brought to you for free and open access by the Theses and Dissertations at Digital Commons @ NJIT. It has been accepted for inclusion
in Theses by an authorized administrator of Digital Commons @ NJIT. For more information, please contact digitalcommons@njit.edu.
Recommended Citation
Moinot, Philippe R., "Design and construction of a novel transpalpebral ophthalmic tonometer" (2008). Theses. 366.
https://digitalcommons.njit.edu/theses/366
 
Copyright Warning & Restrictions 
 
 
The copyright law of the United States (Title 17, United 
States Code) governs the making of photocopies or other 
reproductions of copyrighted material. 
 
Under certain conditions specified in the law, libraries and 
archives are authorized to furnish a photocopy or other 
reproduction. One of these specified conditions is that the 
photocopy or reproduction is not to be “used for any 
purpose other than private study, scholarship, or research.” 
If a, user makes a request for, or later uses, a photocopy or 
reproduction for purposes in excess of “fair use” that user 
may be liable for copyright infringement, 
 
This institution reserves the right to refuse to accept a 
copying order if, in its judgment, fulfillment of the order 
would involve violation of copyright law. 
 
Please Note:  The author retains the copyright while the 
New Jersey Institute of Technology reserves the right to 
distribute this thesis or dissertation 
 
 
Printing note: If you do not wish to print this page, then select  
“Pages from: first page # to: last page #”  on the print dialog screen 
 
  
 
 
 
 
 
 
 
 
 
 
 
The Van Houten library has removed some of the 
personal information and all signatures from the 
approval page and biographical sketches of theses 
and dissertations in order to protect the identity of 
NJIT graduates and faculty.  
 
ABSTRACT
DESIGN AND CONSTRUCTION OF A NOVEL
TRANSPALPEBRAL OPHTHALMIC TONOMETER
by
Philippe R. Moinot
Glaucoma —a degeneration of the optic nerve- is a leading cause of blindness which is
primarily caused by large fluctuations in intraocular pressure (IOP) known as diurnal
variations. Because these peak in the early morning dropping off rapidly, a self
administrable and inexpensive IOP home testing procedure is highly desirable. The
approach contained herein —unlike traditional Goldman applanation tonometry which
requires the use of ophthalmic anesthetics and complex diagnostic equipment- describes a
novel IOP measurement method consisting of concavation of the cornea or sclera through
the palpebra superior by the spherical tip of an optoelectronic photodetector suspended in
a force sensing probe. Three subjects participated in an experiment in which a prototype
device was tested alongside traditional measurement techniques in a clinical setting.
Whilst the device was designed to be initially calibrated to each individual subject for
palpebral color, reflectivity and thickness, uncompensated preliminary data collected
disclose proof of concept.
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CHAPTER 1
INTRODUCTION
1.1 Objectives
The objective of this thesis is to present the chronology of a novel design and
construction proof of concept research project pertaining to a biomedical diagnostic
instrument -and its associated operational protocol- destined for use in the treatment of
glaucoma.
This instrument —a transpalpebral ophthalmic tonometer- is intended —as its name
suggests- to measure a subject's intraocular pressure (IOP) through the palpebra superior
(or upper eyelid). This has come to be accomplished using the combination of an
infrared illuminator array, a hemispherical photodetecting probe tip and a full bridge
strain gage based load cell with their associated signal conditioning circuits and
computational system.
1.2 Background
The following subsections describe the raison d'être for this research project.
1.2.1 Glaucoma Mechanism and Statistics
One leading cause of blindness is glaucoma, which is defined as damage to the optic
nerve resulting in visual field loss. Glaucoma is believed to be most often caused by
elevated IOPs constricting the retinal arteries and veins (Figure 1.1) which lead to and
from retinal ganglion cells (Figure 1.2) which collectively transmit visual information
from the retina to several regions in the thalamus, hypothalamus, and mesencephalon.
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Figure 1.1 Blood supply to and from the eye [7]. 
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Glaucoma cases fall into one of three major categories. These are; primary open 
angle glaucoma -in which Schlemrn' s canal is subject to blockages,- angle closure -in 
which the aqueous humor is prevented from draining around the iris. - (both in Figure 1.3) 
and non-lOP related. The latter category - most often found in subjects of Asian and 
Arctic descent- does not lend itself to use of the novel device described herein as the 
device's operation uniquely conCerns lOP measurement. 
Eye disorders and blindness are estimated to cost the nation more than $16 billion 
annually. [8] Even with proper treatment, 10% of patients afflicted with optic nerve 
degeneration experience loss of vision. 
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Figure 1.2 Gross anatomy [4] (top) and schematic depiction [5] (bottom) of the retina 
in transverse section view. 
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Figure 1.3 Normal and impaired aqueous flow [6]. 
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5Prevent Blindness America estimates that over 3 Million Americans have
glaucoma but only half of those know that they have it. The National Eye Health
Program of the National Institutes of Health approximates that 120,000 are blind from
glaucoma, accounting for 9% to 12% of all cases of blindness in the U.S., that glaucoma
is the leading cause of blindness among African-Americans and that two million
Americans currently have glaucoma. [8] Other studies estimate that due to the aging
population this number will increase to 3.3 million by 2020. [9]. The World Health
Organization lists glaucoma as the second leading cause of blindness in the world.
Estimates put the total number of suspected cases of glaucoma at around 65 million
worldwide.
The critical measurement attained in the management of a patient's vision with
glaucoma is intraocular pressure (TOP) using a tonometer. Researchers have shown that
IOP varies throughout the day [1] and glaucoma patients only have their IOP measured
every few months. [10] Other health sectors have home monitoring devices that are
critical in the management of disease such as glucometers which measure glucose levels
for diabetics and blood pressure monitors both of which are routinely used in the home.
Analogously, if an ophthalmologist could instruct his patients to monitor IOP periodically
throughout the day, the management of the patient's vision with glaucoma would be
dramatically improved by slowing their resistance to IOP lowering medications. Our
research team is actively involved in research, development and validation of point-of-
care tonometer devices.
61.2.2 Glaucoma Factors
There is no cure for glaucoma. As a chronic condition, life long monitoring of
intraocular pressure (lOP) is required. With proper IOP monitoring and corresponding
administration of medication, further degeneration can be halted. It was long thought that
static elevated IOPs were the main cause of glaucoma. Recent studies have revealed that
elevated changes in pressure known as diurnal variations are of primary concern in the
progression of blindness in glaucoma patients [1]. Furthermore, studies indicate that IOP
is actually at its highest first thing in the morning before a patient can go to their
physician's office [2]. For this reason, an inexpensive home based measurement
technique is highly desirable.
1.2.3 Traditional Diagnostic Techniques
The gold standard for ophthalmic tonometry has long been Goldman applanation
tonometry. This procedure —routinely performed in common eye examinations- involves
the applanation (or flattening) of the cornea (or lens) —using the combination of a
truncated conic optic element and a slit lamp projector (Figure 1.4)- subsequent to the
application of a topical ophthalmic anesthetic. The applied force required to produce a
given amount of applanation correlates quite well to the intraocular pressure. Though not
terribly invasive, this procedure does require anesthetics and bulky, high precision and
expensive diagnostic equipment and must me administered by a trained physician or
clinician.
• 
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Figure 1.4 Goldman applanation tonometer (left), applanation optic and slit lamp 
(middle) and mires (right) which indicate degree of applanation. 
The eyeball surface is composed of the sclera (white of the eye) and cornea 
(transparent tissue distal to the lens). The Imbert-Fick Law shows that when 
approximating the eyeball as a sphere, the lOP will be equal to the applied force divided 
by the contact area of a fully applanating tip pressed upon the cornea. Mackay and Marg 
showed that lOP can be determined in this way with the use of an excursion limiting ring 
coaxial to the corneal applanation tip. Where sufficient force is applied directly to the 
, 
cornea for applanation to occur beyond the inner diameter of the ring, an j.nflection point 
in the force versus time curve is created. At this point the lOP is equal to the force 
applied divided by the tip area. [11 J 
Our tonometer design operates In much the same manner, but uSing a 
hemispherical - rather than flat- tip applied to the cornea through the eyelid eliminating 
the need for anesthetics. Furthermore, rather than relying on a skilled clinician to provide 
a time-linear application of force , we introduce a second sensor -in addition to the force 
sensor- which optoelectronically measures obscuration (tip penetration) eliminating 
dependence on the time variable. Unlike Mackay Marg's, which was intended for the 
clinic, our tonometer will be used by the patient at home. 
8Intraocular pressure (lOP) is monitored in glaucoma patients with measurement
intervals ranging from days to months rather than hours. [10] Tonometry performed
during routine glaucoma examinations thus only provides the physician with a glimpse of
intraocular pressure. Asrani and colleagues showed that although patients had similar
average and standard deviation for home and office IOP, large fluctuations in diurnal IOP
were still a significant risk for glaucoma progression. [1] The magnitude of the
variations in IOP is also potentially an important clinical indicator since it is correlated
with loss of visual field. [1] Zeimer and colleagues concluded that peaks in IOP tend to
occur in the early morning, typically right after waking before a patient can reach the
clinic, and may have an effect on loss of vision. [2] There is therefore a clinical need for
an effective point-of-care tonometry method, particularly one that would allow a patient
to measure his IOP between yisits to decrease vision loss associated with glaucoma.
Typical clinical tonometers, such as the Goldman tonometer, utilize direct corneal
applanation, which requires anesthetizing the eye. Although these instruments are
accurate and precise, they are not practical for home monitoring, as many patients would
have difficulty applanating their own cornea, and there is no approved topical anesthetic
for home use. One "home" tonometer developed by Zeimer and colleagues requires a
topical anesthetic or the use of a contact lens. [13] A preferable tonometer would not
require anesthetic and would be simple to use, sufficiently accurate and most of all
inexpensive.
Fresco and Dayman have invented a method and a device based on the principle
that pressure applied to the sclera generates a phosphene spot, a self-perceptible visual
phenomenon. [14] The Proview ™  Eye Pressure Monitor is a phosphene tonometer
9approved by the FDA and recently marketed by Bausch & Lomb. Our team's -including
Alvarez and colleagues [3]- clinical evaluation compared the Proview ™  with the
Goldmann tonometer and yielded a correlation coefficient of r=0.41. The sensitivity of
the Proview™  technique to detect patients with high IOP was low, since the value of the
Proview™  pressure only identified 18% (4/22) of these patients. In other words, the
Proview™  failed to detect high pressure in 4 out of 5 patients with glaucoma, the key
market application for this device. Clearly, this tonometer does not meet its market
requirements. This further indicates the need for a home use tonometer for the
management of a glaucoma patient's vision.
Increased IOP is an indicator of glaucoma. Several researchers state the need for
patients to be able to measure their IOP regularly at home. [1][12][13][14] Many home
tonometers on the market are not reliable. [3][12] Those on the market in Europe and
proposed elsewhere require an anesthetic because the devices are painful and thus
unsuitable for home use in the US. [15] In this project, we developed, clinically
evaluated, and improved a tonometer for patients with glaucoma. Our team has evaluated
the Proview™  and published in the peer reviewed journal Ophthalmology our findings
that this FDA approved tonometer marketed by Bausch & Lomb only detects high
pressure in 1 out of 5 patients who have glaucoma. This device clearly does not meet the
clinical need. We have developed a proprietary concept through IRB approved clinical
studies, including preliminary data that suggest clinical potential. We have used the same
methodology to correlate performance of our tonometer against the clinical gold standard
Goldman tonometer using the protocol developed by Dr. Fechtner for our evaluation of
the Proview ™  product. Given successful development and validation, the NJIT
10
tonometer shall provide precise and accurate IOP measurement for glaucoma patients in
the convenience of their own homes decreasing the amount of visual field loss and
enabling timely and accurate determination of the timing and dose of drug required to
optimally maintain normal physiological levels of IOP.
Other IOP measurement approaches have been successfully realized, but they all
lack in self-administrable ease of use and / or are exceedingly expensive. Previous
attempts at home based, inexpensive and self-administered IOP tests have proven
ineffective [3].
CHAPTER 2
HOME BASED IOP TESTING
2.1 Problem Statement
What is required for the proper care of glaucoma patients is a personal IOP measurement
diagnostic device which may be used upon waking —when IOPs are known to peak- in
order to properly regulate the administration of their IOP stabilizing medications. When
compared to currently available methods, this device and its associated operational
protocol should be relatively inexpensive and easily self administrable, comfortable and
completely non-invasive. It should be small, lightweight, power thrifty and require little
to no maintenance.
2.2 Design Solution Parameters
The following subsections enumerate and describe the design constraints implemented to
address the problems listed in the latter section.
2.2.1 Cost
In order to make the device available to all glaucoma patients, it must be designed for a
manufacturing cost of approximately twenty dollars enabling a retail cost to the patient of
less than one hundred dollars plus the expense of a one time clinical visit for initial
calibration. This excludes the use of exotic materials and components, as well as time or
expendables intensive manufacturing techniques.
11
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2.2.2 Ease of Use
The device should require little training and no special skills to use. The design should
lend itself to a device that is small enough to easily tuck into a pocket and comprise its
own low maintenance power source such as lithium coin cells. It should also be easy to
clean and fairly resistant to environmental contamination.
2.2.3 Comfort
To encourage regular use of the device, it should cause the patient to experience little to
no discomfort without the use of anesthetics. This precludes any direct contact with the
surface of the eye.
CHAPTER 3
IMPLEMENTATION
3.1 Operating Principle
The current device has gone through several iterations which will be described in detail
below. The following refers to Figure 3.1 which schematically depicts the device's
operating principle and components.
Figure 3.1 Operating principle schematic.
A hemispherically tipped infrared photodiode (cyan) housed in a tapered cylinder
is manually pressed upon the palpebra superior via a spring loaded outer housing. The
outer housing incorporates a displacement sensor (magenta) as well as an illuminator ring
(rays in red). As the probe is pressed onto the eye with increasing force, the
13
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photodetector is gradually obscured yielding a measure of penetration. IOP can then be
extrapolated as a function of probe tip penetration with respect to the applied force which
is measured by the spring and displacement sensor combination.
3.2 Scope of Prototyping
This section describes the purpose -or expected benefits- for the form of this prototype
device's design and construction.
3.2.1 Concept Limitation
The variability of palpebral geometry and coloration —most notably its thickness,
elasticity and reflectivity at the illuminator's wavelength- necessitate calibration of the
device —at least computationally- to each subject. Due to the aforementioned limitation,
verifying operational details such as gain and linearity would require standards
comparison testing at a minimum of two and three significantly different IOPs per subject
respectively.
3.2.2 IRB Limitations
At the current stage of concept development, obtaining IRB approval for altering an
approved test subject's IOP through the administration or suspension of medications is
not justified limiting our ability to fully evaluate the aforementioned operational details.
3.2.3 Clinical Limitations
It was hoped that side by side comparison testing between Goldman applanation
tonometry and the prototype device would yield appreciable correlation data within each
subject when performed in a standing position both pre and post a ten minute supination
F 
15 
period. [14] [16] However, the supination period failed to significantly affect the lOP as 
measured in the Goldman reference tests. 
3.2.4 Resulting Scope 
For these reasons, in anticipation of broadening IRB approval, prototype construction and 
testing were limited to proving that the mechanism's design would exhibit a specific 
relationship in terms of penetration with respect to applied force. That relationship being 
that the palpebral compressible region does not intersect that of the cornea or sclera. In 
other words, that the penetration with respect to applied force function would indicate -
within a range of applied force- separate .compressible regions for the palpebra and 
cornea or sclera such that the palpebral compressibility might be disregarded. 
3.3 Prototype Design and Construction 
, 
Several years of design and experimentation have led to the creation ,of the current 
prototype. This section depicts a synopsis ofthe design cycle. 
3.3.1 Photodetecting Probe Tip 
As the basis for the operating concept, the design of the probe tip (Figure 3.2) has 
Figure 3.2 Stainless steel probe housing showing maximum protrusion setting of 
hemispherical photodetecting probe tip (calibration shims were uninstalled.) 
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changed little since the project's inception. The probe tip consists of a standard T1-3/4
rimmed hemispherically tipped infrared photodiode housed in a tapered 316 stainless
steel cylinder. The photodiode's protrusion distance is controlled by the thickness of a
replaceable spacing washer placed between the face of a step in the cylinder's bore and
the photodiode's rim. The photodiode and spacer are held in place from behind by a
bored and slotted nylon 6/6 (nonconductive) setscrew through which the photodiode's
two conductors are passed.
3.3.2 Force Sensing Mechanism
The original design for the force sensing mechanism involved the creation of a custom
linearly variable differential transformer (LVDT) and spring assembly (Figure 3.3). This
design showed some promise but was abandoned due to tradeoffs in lateral rigidity versus
friction factors. All subsequent designs incorporated a subminiature full bridge strain
gage based shear beam load cell (Figure 3.4). This type of load cell's operating
principle —as depicted in Figure 3.5- involves four strain gages operating in opposing
pairs to form the legs of a full bridge. In order to operate properly, the reactive torques
generated by the beam must be constrained to maintain parallelism in the beam ends.
This maintains one pair of strain gages in tension and one pair in compression.
----------
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Figure 3.3 Abandoned LVDT and spring assembly. 
17 
18 
Figure 3.4 Subminiature full bridge strain gage based shear beam load cell. 
i 
TENSION~ 
Figure 3.5 Load cell geometry. 
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3.3.3 Suspension Mechanism
The incorporation of several different probe tip and load cell suspension and constraint
mechanisms was attempted.
The first attempt simply involved the use of a stainless steel block and brass
bushing arrangement. This arrangement revealed drawbacks similar in nature to the
LVDT force sensing arrangement.
The next mechanism (Figures 3.6) —in an effort to reduce friction and increase lateral
constraint- incorporated a lever arm suspended by two axially aligned bearings. This
arrangement showed great improvement but there still existed significant sensitivity to
the application of lateral forces.
, 
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This was all but completely ameliorated in the most recent redesign which 
incorporates one of the world ' s smallest dual recirculating linear ball slide mechanisms 
(Figure 3.7). 
Figure 3.7 Dual recirculating linear ball slide. 
3.3.4 Illuminator 
f 
, 
The original illuminator concept (Figure 3.8) comprised a brass bushed backlit 
polymethylmethacrylate lightpipe. In order to facilitate testing of the device's other 
subassemblies - namely the force sensing components,- this idea was set aside in favor of 
a more accessible and manipulable - though admittedly less streamlined- direct projection 
system. 
.. 
• 
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Figure 3.8 Lightpipe illuminator. 
Figure 3.9 Infrared thermograph of uniform illumination field around probe tip 
(imaged using a chilled CCD detector to minimize thermal noise.) 
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Several light emitting diode (LED) sources of varying wavelength and dispersion
angle and various mounting positions were tested until an acceptable —uniform and
continuous- illumination field (Figure 3.9) was developed.
3.3.5 Signal Conditioning
The signal conditioning circuitry is fairly straight forward. The infrared LED illuminator
array (Figure 3.10) is driven by a 0 to 10 volt digital to analog converter (DAC) via a
resistive voltage divider network and an NPN bipolar junction transistor emitter follower
circuit which serves to boost the available current to a suitable drive level.
Figure 3.10 IRLED illuminator circuitry.
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The decision to control the illuminator via DAC was made to facilitate
modulation. Modulating the illumination could serve —when combined with detector
filtering- to automatically reject low frequency noise and offset errors introduced by
ambient lighting. In testing it was found that noise in subdued ambient lighting was
sufficiently negligible and the DAC has since served in a static dimming capacity to
calibrate the illuminator level well below that of detector saturation.
The photodetector circuit (Figure 3.11) is equally simple. It consists of a
negatively biased photodiode feeding an analog to digital converter (ADC) via a high (10
Megaohm) input impedance (HI-Z) non-inverting amplifier with a gain that may be
varied up to approximately 200 using a 200 kiloohm multiturn trimmer potentiometer.
Figure 3.11 Photodetector circuitry.
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The force sensing circuit (Figure 3.12) consists of the aforementioned full bridge
strain gage based load cell from Figure 3.4, biased with +5 volts, and feeding an ADC via
an instrumentation amplifier with a nulling network added to the non-inverting leg of the
summing amplifier section. Offset null and gain are adjusted via 20 kC2 multiturn
potentiometers.
Figure 3.12 Load cell signal conditioning circuitry.
All of the acquisition signal conditioning circuitry (Figure 3.13) was assembled
on a small thru-plated hot leveled tin perforated breadboard with pad to pad Teflon
insulated jumper wiring designed to sit in the prototype's sensing head to minimize HI-Z
transmission length. All but the 10MΩ fixed resistors are SMDs mounted on the back.
F 
Figure 3.13 Signal conditioning circuitry from sensing head corresponding to 
schematic diagrams in Figures 3.11 and 3.12. Potentiometers from top to bottom are 
photodiode gain, loadcell offset and loadcell gain. 
3.3.6 Sensing Head Assembly 
26 
The completed sensing head (Figure 3.14) is assembled in a tapered pocket machined 
acetal (Delrin) polymer block. The circuit board, linear rail and one end of the load cell 
,-
are attached to the base of the milled pocket. The other end of the load cell and the probe 
tip are attached to the linear rail carriage via a hollow cube shaped aluminum bracket. 
Figure 3.14 Sensing head showing photodetecting probe tip and six element IR 
illuminator (left) and signal conditioning circuitry, cube shaped angle bracket riding on 
recirculating ball slide, loadcell assembly and tether cable connector (right). 
- - - - ---------
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The sensmg head is tethered to a polycarbonate enclosure (Figure 3.15) 
containing power conditioning and isolation circuitry, the illuminator's driver transistor 
and BNC terminated pigtails which connect to the data acquisition card 's (DAQ' s) ADCs 
and DAC ports. A second level of isolation is provided by a medically isolated Ault 
brand MWI17 switching power supply. The complete system can be seen in Figure 3.16. 
3.3.7 Data Acquisition System 
At the current stage of concept development, in lieu of interfacing to, and programming a 
microcontroller IC, it was decided that data acquisition using a personal computer and 
DAQ would be more illustrative. The Daqboard2000 DAQ and associated DBK206 
breakout board manufactured by IOTECH were selected and configured for use with 
National Instruments' Labview virtual instrument (VI) development environment. 
Figure 3.15 Power conditioning and signal junction circuitry showing (from left to 
right) 3 BNC connectors (2 ADC and I DAC) for PC DAQ card, quick disconnect for 
sensing head's tether cable, power transistor for IR LED drive, isolated DC to DC power 
converter modules, external power supply quick disconnect and supply. 
• 
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Two VIs (Figure 3.17 and detailed in the appendix) were implemented to control 
the DAC and coordinate the acquisition from the two ADCs. The ADCs are continuously 
sampled at a repetition rate of 1000 Hertz until the applied force reaches 95 grams at 
which point the data buffer is transferred to an Excel file for later analysis. 
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Figure 3.17 Virtual instruments. 
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CHAPTER 4
RESULTS
4.1 Clinical Trial
Three subjects participated in a clinical trial which involved —in order of execution- the
following procedures:
• Goldman applanation tonometry was performed on both eyes. [14]
• Sampling with the prototype device was performed on both eyes.
• Subjects laid supine for approximately 10 minutes. [14] [16]
• Goldman applanation tonometry was again performed on both eyes.
• Sampling with the prototype device was again performed on both eyes.
4.1.1 Goldman Applanation Tonometry
Goldman applanation tonometry was performed using the standard protocol -as briefly
described herein in section 1.2.3 and Figure 1.4- by an ophthalmic clinician at the
University of Medicine and Dentistry of New Jersey at the Newark, New Jersey campus
in accordance with IRB approval.
4.1.2 Prototype Device Sampling
The prototype device's DAQ was configured to begin sampling once the output of the
photodetector circuit reached below a preset (negative) threshold voltage which is
indicative of illuminator reflection and thus of the probe tip approaching the palpebra.
Likewise, the DAQ was configured to stop sampling and save the data to an Excel
compatible comma delimited file once the load cell circuit's output voltage reached a
30
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preset threshold indicating that sufficient force was applied. Subjects were asked to
conduct the test on themselves under our team's supervision with the test consisting of
closing each eye's palpebra and touching it with the probe tip four or five times.
Purely for the reader's amusement, Figure 4.1 illustrates the results of three
typical tests in the form of three stereograms. Those readers capable of converging upon
the stereo pairs —crossing their eyes slightly as they hold the page straight and at arms
length- can view these images in 3D.
F 
32 
Figure 4.1 Stereoscopic images of three typical time sample series. 
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Data from tests which timed-out prior to completion were discarded and the tests 
repeated after the subjects were instructed to proceed in a faster more fluid motion. 
It can be seen that the curves are ill-behaved in the time domain but this variable 
can be eliminated as illustrated by a 20 scatter plot (Figure 4.2). 
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Figure 4.2 Scatter plot of typical test data. The vertical region on the left 
10 
corresponds to obscuration of the probe tip just prior to contact with the palpebra. 
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Fitting a 6th order polynomial as drawn in red in Figure 4.3 illustrates the expected 
response consisting of palpebral compression (up to around 20g), corneal pre-
compression (20g to 35g), and corneal compression (35g to 60g). 
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Figure 4.5 Subject # 1 pre-supine averages of 5 trials are: L=5.5mV /g, R=8.0mV/g. 
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A linear interpolation (Figure 4.4) of the latter region —who's slope shall be called
corneal compliance in mV/g- was conducted (Figures 4.5 — 4.10) -averaging corneal
compliances of each eye's tests- yielding the twelve compliance results in Table 4.1 (one
for each eye of the three subjects both pre and post the supination period). The reciprocal
of the compliance —which shall be called corneal rigidity- is then calculated as
1000
Compliance
as it better compares to the Goldman Reference test.
Table 4.1	 Experimental Results
Subject Compliance
mV/g
Rigidity
WV
Goldman Reference
mmHg
#1 Pre-sup., Left eye 5.5 182 19
#1 Pre-sup. Right eye 8.0 125 17
#2 Pre-sup. Left eye 5.5 182 20
#2 Pre-sup. Right eye 5.4 185 20
#3 Pre-sup. Left eye 12 83 14
#3 Pre-sup. Right eye 10 100 15
#1 Post-sup. Left eye 5.2 192 20
#1 Post-sup. Right eye 7.8 128 17
#2 Post-sup. Left eye 7.0 143 18
#2 Post-sup. Right eye 4.8 208 21
#3 Post-sup. Left eye 11 91 14
#3 Post-sup. Right eye 14 71 12
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CHAPTERS 
CONCLUSION 
5.1 Comparison 
The experimental results in Table 4.1 are compared in Figure 5.1 by plotting the rigidity 
values measured using the prototype device with respect to the reference standard 
pressure measured by Goldman applanation tonometry. 
250 
0 
>ll 
0 
0 
~ I 
~ 150 
i 0 f 
~ 8 
100 0 I '~~O~B I 
0 
0 
50 
°5L-------~~~1O~-----------,~5------------~------------~3 
Pressure (mmHg) 
Figure 5.1 Correlation coefficient for prototype device versus Goldman applanation. 
Considering that no subject specific calibration was performed on the prototype 
device, the computation of a Pearson correlation coefficient of 0.9828 is by far more 
impressive than had ever been expected. 
It is clear that this design concept is sound and merits further development. 
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5.2 Future Work 
Here are some thoughts on future development for production economization, 
miniaturization and improving reliability and ease of use. 
5.2.1 Illuminator Design 
Redesign of the illuminator is likely to be one of the most significant size reduction 
factors in migrating from conceptual prototype to production design. One space saving 
idea involves illumination delivery the via optical fibers embedded into and protruding 
from the periphery of the probe tip. 
5.2.2 Linear Guide Mechanism 
One of the costliest components incorporated into the prototype is the dual recirculating 
linear ball slide. The slide could be replaced by a less costly set of six microminiature 
ball bearings arranged radially in two sets of three around a hexagonal sliding center 
shaft. 
5.2.3 Intuitive Azimuthal Orientation 
Off axis application of the device seems to be one of the leading causes of erroneous 
readings. One idea for providing intuitive orientation feedback would involve replacing 
the photodiode with a transparent optical component of similar shape which would 
incorporate a ring of photodetectors as well as a thinly collimated visible light source 
delivered via an opaque tube at the component's center. By keeping the light in view 
while performing the tests, a subject would be assured of keeping the probe normal to the 
surface of the eye. 
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APPENDIX 
LABVIEW DATA ACQUISITION VIRTUAL INSTRUMENT BLOCK 
DIAGRAMS 
Figure A.I depicts the overview of the Labview virtual instruments (VIs) block 
diagram used for data acquisition in the clinical trials. 
(j] 
Figure A.I Labview VIs block diagram overview. 
The data acquisition system which was used (an IOTech Daqboard 2000 and its 
associated DBK206 screw terminal breakout card) allows for autonomous buffered block 
sampling. The first of the initialization VIs (Figure A.2) is used to set the number of 
autonomous samples to I and to initialize an error flag to 'false'. 
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Figure A.2 Acquisition initialization VI. 
The next block in the initialization path (Figure A.3) appends the identification 
label 'DaqBoard2kO' which points to the specific DAQ board to be used. 
I DaqBoard2kD 
Individual ACQuisitions I 
c... DAQIO 
-
DAQIO 
-ACQ LOCATE 
-
IN IT NAME ~ 
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Figure A.3 Board enumeration. 
The next two VIs in the chain (Figures A.4 and A.5) incorporate the list of 
channels to acquire from (channels 0 for force and 1 for illumination in this case) as well 
as which channels should be considered -and how- in start and stop triggering. In this 
case, acquisition is set to start automatically (no start trigger) and to stop if the loadcell 
registers in excess of 95 grams. 
Daq Channels 
~. 
DAQIO 
DA:;.t -
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Figure AA Channel and trigger enumeration. 
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Figure A.S Trigger parameters. 
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The last two VIs (Figure A.6) that are included prior to the execution thread 
entering the sampling 'while loop' set the number of single sample scan iterations (1500 
here) and the delay interval between them (lms here) and then arm the acquisition 
subsystem. This provides 1.5 seconds in which to complete each trial. Sampling is 
automatically restarted until the force threshold is reached. 
Figure A.6 Scans. 
I 
Within the 'while loop' (Figure A.7), a sample from each chanhel is acquired 
every millisecond and stored in a data array. If an error occurs of if the force threshold is 
reached, the data array is output to a prenamed Excel compatible text file. If the 
acquisition 'times out' , the while loop simply restarts. 
- -------------------
Figure A.7 While loop. 
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